相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced degradation of mutant huntingtin by rho kinase inhibition is mediated through activation of proteasome and macroautophagy
Peter O. Bauer et al.
AUTOPHAGY (2009)
Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies
S. Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2009)
Effects of overexpression of Huntingtin proteins on mitochondrial integrity
Hongmin Wang et al.
HUMAN MOLECULAR GENETICS (2009)
Phosphorylation of Eukaryotic Translation Initiation Factor 2α Coordinates rRNA Transcription and Translation Inhibition during Endoplasmic Reticulum Stress
Jenny B. DuRose et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
PGC-1 alpha as modifier of onset age in Huntington disease
Elahe Taherzadeh-Fard et al.
MOLECULAR NEURODEGENERATION (2009)
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity
Martin L. Duennwald et al.
GENES & DEVELOPMENT (2008)
Suppression of mutant huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability
Sayuko Kaminosono et al.
JOURNAL OF NEUROSCIENCE (2008)
Transcriptional activators HAP/NF-Y rescue a cytochrome c oxidase defect in yeast and human cells
Flavia Fontanesi et al.
HUMAN MOLECULAR GENETICS (2008)
Global changes to the ubiquitin system in Huntington's disease
Eric J. Bennett et al.
NATURE (2007)
A toxic monomeric conformer of the polyglutamine protein
Yoshitaka Nagai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
被撤回的出版物: A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy (Retracted Article. See vol 16, pg 2647, 2007)
May Christine V. Malicdan et al.
HUMAN MOLECULAR GENETICS (2007)
Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III
Asun Solans et al.
HUMAN MOLECULAR GENETICS (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Flanking sequences profoundly alter polyglutamine toxicity in yeast
Martin L. Duennwald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers
Sviatoslav Sokolov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin
A Benchoua et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease
C Vacher et al.
HUMAN MOLECULAR GENETICS (2005)
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease
F Giorgini et al.
NATURE GENETICS (2005)
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway
QM Ruan et al.
HUMAN MOLECULAR GENETICS (2004)
Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death
CM Haynes et al.
MOLECULAR CELL (2004)
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
E Trushina et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release
YS Choo et al.
HUMAN MOLECULAR GENETICS (2004)
The human TAZ gene complements mitochondrial dysfunction in the Yeast taz1Δ mutant -: Implications for Barth syndrome
LN Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Huntingtin and the molecular pathogenesis of Huntington's disease - Fourth in molecular medicine review series
C Landles et al.
EMBO REPORTS (2004)
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein
S Willingham et al.
SCIENCE (2003)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria:: relevance to Huntington's disease
AV Panov et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis
AB Meriin et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
AV Panov et al.
NATURE NEUROSCIENCE (2002)
Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1
AB Meriin et al.
JOURNAL OF CELL BIOLOGY (2002)
Shy1p is necessary for full expression of mitochondrial COX1 in the yeast model of Leigh's syndrome
A Barrientos et al.
EMBO JOURNAL (2002)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts
DG Nicholls et al.
TRENDS IN NEUROSCIENCES (2000)
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins
S Krobitsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
CREB-binding protein sequestration by expanded polyglutamine
A McCampbell et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
